SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Femasys Inc. (FEMY) News

Track canonical SquawkNews coverage tagged to FEMY, Femasys Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 9 indexed stories across 8 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol FEMY Asset equity Sector Markets 90 days 8 Last 2.13 Updated Sep 15, 2026, 01:00 PM UTC Open live news feed
L FEMY - Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care FEMY - Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care NEWS | Sep 15, 2026, 01:00 PM UTC L Femasys partners with CapexMD to expand FemaSeed patient access Femasys said its collaboration with CapexMD will provide dedicated patient financing for its FemaSeed fertility solutions across OB/GYN practices and fertility centers, aiming to reduce financial barriers to care. EQUITY | Sep 09, 2026, 01:03 PM UTC L FEMY partners with CapexMD to expand patient access Femasys partners with CapexMD to expand patient access to its FemaSeed fertility portfolio. EQUITY | Sep 09, 2026, 01:01 PM UTC L Femasys files SEC resale for up to 28,124,997 shares of common stock Femasys (FEMY) filed an SEC registration for the resale of up to 28,124,997 shares of common stock. REGULATION | Sep 03, 2026, 09:53 PM UTC L Femasys partners with UNC Health to expand FemaSeed fertility portfolio Femasys Partners with UNC Health to introduce its FemaSeed fertility portfolio across statewide OB/GYN care locations. EQUITY | Aug 26, 2026, 01:00 PM UTC M Femasys FDA approves modular PMA submission approach for FemBloc® Femasys announces FDA approval of a modular PMA submission approach for its FemBloc® device. REGULATION | Aug 19, 2026, 01:00 PM UTC L Femasys reports quarter ended June 30, 2026 financial results Femasys announces financial results for the quarter ended June 30, 2026 and provides a corporate update. EARNINGS | Aug 14, 2026, 08:05 PM UTC L FEMY Strengthens Patent Protection Femasys strengthens global patent protection for FemBloc with issued blended polymer patents EQUITY | Aug 12, 2026, 01:00 PM UTC L FEMY Regains Compliance Femasys regains compliance with Nasdaq listing requirements REGULATION | Jun 24, 2026, 01:00 PM UTC